Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Double-Blind Controlled Trial of Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis

NCT04806373 is registered in ClinicalTrials.gov with Memorial Healthcare System as lead sponsor.

NCT NCT04806373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04806373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Double-Blind Controlled Trial of Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis
Lead sponsor
Memorial Healthcare System
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2021
Completion date
December 14, 2023
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pleural effusion